Santhera Gets First Duchenne Drug OKd Under UK Early Access Scheme

 
• By Neena Brizmohun
  
DMD
Santhera's unlicensed drug can now be used to treat UK patients with Duchenne • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet